Skip to main content

Advertisement

SpringerLink
Log in

Journal Watch

  • News
  • Published:
Molecular Diagnosis & Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Bonanno L, Favaretto A, Rugge M, et al. Role of genotyping in non-small cell lung cancer treatment: current status. Drugs 2011; 71(17): 2231–46

    Article  PubMed  CAS  Google Scholar 

Reference

  • Fosker C, Adlard JW, Shaaban A. Tailoring therapy for locally advanced breast cancer using molecular profiles: are we there yet? Drugs 2011; 71(15): 1947–55

    Article  PubMed  CAS  Google Scholar 

Reference

  • Song S-H, Han S-W, Bang Y-J, et al. Epigenetic-based therapies in cancer: progress to date. Drugs 2011; 71(18): 2391–403

    Article  PubMed  CAS  Google Scholar 

Reference

  • Williams VL, Torres-Cabala CA, Duvic M. Primary cutaneous small-to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category. Am J Clin Dermatol 2011; 12(6): 389–401

    Article  PubMed  Google Scholar 

Reference

  • Sung C, Lee PL, Tan LL, et al. Pharmacogenetic risk for adverse reactions to irinotecan in the major ethnic populations of Singapore: regulatory evaluation by the Health Sciences Authority. Drug Saf 2011; 34(12): 1167–75

    Article  PubMed  CAS  Google Scholar 

Reference

  • vanKuilenburg ABP, Häusler P, Schalhorn A, et al. Evaluation of 5-fluorouracil pharmacokinetics in cancer patients with a c. 1905+1G>A mutation in DPYD by means of a Bayesian limited sampling strategy. Clin Pharmacokinet 2012; 51(3): 163–74

    Article  PubMed  Google Scholar 

Reference

  • Kwok CS, Loke YK. Effects of proton pump inhibitors on platelet function in patients receiving clopidogrel: a systematic review. Drug Saf 2012; 35(2): 127–39

    Article  PubMed  CAS  Google Scholar 

Reference

  • Verstuyft C, Delavenne X, Rousseau A, et al. A pharmacokinetic-pharmacodynamic model for predicting the impact of CYP2C9 and VKORC1 polymorphisms on fluindione and acenocoumarol during induction therapy. Clin Pharmacokinet 2012; 51(1): 41–53

    Article  PubMed  CAS  Google Scholar 

Reference

  • Cai J, Huang Z, Yang G, et al. Comparing antihypertensive effect and plasma ciclosporin concentration between amlodipine and valsartan regimens in hypertensive renal transplant patients receiving ciclosporin therapy. Am J Cardiovasc Drugs 2011; 11(6): 401–9

    Article  PubMed  CAS  Google Scholar 

Reference

  • Manzoli L, De Vito C, Marzuillo C, et al. Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis. Drug Saf 2012; 35(3): 191–205

    PubMed  CAS  Google Scholar 

Reference

  • Panetta F, Nobili V, Sartorelli MR, et al. Celiac disease in pediatric patients with autoimmune hepatitis: etiology, diagnosis, and management. Paediatr Drugs 2012; 14(1): 35–41

    Article  PubMed  Google Scholar 

Reference

  • Broughton T, Armon K. Defining juvenile idiopathic arthritis remission and optimum time for disease-modifying anti-rheumatic drug withdrawal: why we need a consensus. Paediatr Drugs 2012; 14(1): 7–12

    Article  PubMed  Google Scholar 

Reference

  • Fabre S, Apparailly F. Gene therapy for rheumatoid arthritis: current status and future prospects. Drugs 2011; 25(6): 381–91

    CAS  Google Scholar 

Reference

  • de laMonte SM. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer’s disease. Drugs 2012; 72(1): 49–66

    Article  PubMed  Google Scholar 

Reference

  • Roerig JL, Steffen KJ, Mitchell JE. Atypical antipsychotic-induced weight gain: insights into mechanisms of action. CNS Drugs 2011; 25(12): 1035–59

    Article  PubMed  CAS  Google Scholar 

Reference

Reference

  • Ingles J,McGaughran J, Scuffham PA, et al. A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy. Heart. Epub 2011 Nov 29

References

  1. Lala A, Sharma G, Hochman JS, et al. Genetic testing in patients with acute coronary syndromes to determine optimal anti-platelet strategy: a cost effective analysis [abstract no. 15474]. Circulation 2011; 124 (21 Suppl.): A15474 [online]. Available from URL: http://circ.ahajournals.org/cgi/content/meeting_abstract/124/21_MeetingAbstracts/A15474?sid=a91cd2cb-6ada-48ca-8921-7f4235765cdd [Accessed 2012 Mar 20]

  2. Hillegass WB, Zoghbi G, Brott BC, et al. Cost-effectiveness of new oral anti-platelet agents and testing strategies during early invasive management of acute coronary syndrome patients [abstract no. 18228]. Circulation 2011; 124 (21 Suppl.): A18228 [online]. Available from URL: http://circ.ahajournals.org/cgi/content/meeting_abstract/124/21_MeetingAbstracts/A18228?sid=22f85df4-f3ec-4b49-a680-112eb0788156 [Accessed 2012 Mar 20]

References

  1. Holt SDH, Bennett H, Bertelli G, et al. Cost-effectiveness evaluation of the Oncotype DX® breast cancer assay in clinical practice in the UK [abstract no. PD06-02]. Cancer Res 2011; 71(24 Suppl.): 136s [online]. Available from URL: http://www.sabcs.org/UserPortal/Documents/Abstract_Book_SABCS_20111215.pdf [Accessed 2012 Mar 20]

    Google Scholar 

  2. Lacey L, Chien R, Hornberger J. Cost-utility of the 21-gene breast cancer assay (Oncotype DX®) in the Irish healthcare setting [abstract no. P1-10-04]. Cancer Res 2011; 71(24 Suppl.): 213s [online]. Available from URL: http://www.sabcs.org/UserPortal/Documents/Abstract_Book_SABCS_20111215.pdf [Accessed 2012 Mar 20]

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Journal Watch. Mol Diagn Ther 16, 125–133 (2012). https://doi.org/10.1007/BF03256437

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03256437

Search

Navigation